News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • Dana-Farber scientists find when given together, two orally available experimental drugs – sapacitabine and seliciclib – worked together to elicit antitumor effects in patients with incurable BRCA-deficient cancers.

Tags: BasicResearch, BreastCancer, PancreaticCancer, GynecologicCancers

  • Kornelia Polyak, MD, PhD, was presented with the 2012 AACR Outstanding Investigator Award for Breast Cancer Research at the 35th annual CTRC-AACR San Antonio Breast Cancer Symposium.

Tags: BasicResearch, BreastCancer, Honors

  • Erica Mayer, MD, MPH, and colleagues are leading a pilot phase 2 clinical trial to test the feasibility of the targeted drug palbociclib combined with endocrine therapy as adjuvant therapy for stage II and III breast cancer.

Tags: BreastCancer, TargetedTherapy

  • A novel pairing of two cancer drug types showed promising activity and had manageable toxicities, according to a first-of-its-kind clinical trial led by scientists at Dana-Farber Cancer Institute.

Tags: BreastCancer, OvarianCancer, GynecologicCancers

  • Results from a study evaluating an oral daily dose of the drug enobosarm, shows promise for women with metastatic, androgen receptor positive, estrogen receptor positive breast cancer.

Tags: BreastCancer, TargetedTherapy

  • Researchers at Dana-Farber have developed a tool to help predict how a patient’s tumor is likely to behave and which of several possible treatments is most likely to be effective.

Tags: BreastCancer, Genetics

  • A new study finds many breast cancer patients don't know the characteristics of their own disease, such as cancer stage and tumor grade.

Tags: BreastCancer, PatientEducation

  • In a new study examining disparities in postmastectomy breast reconstruction, researchers at Brigham and Women's Hospital and Dana-Farber concluded that lack of patient-provider discussion may contribute to socioeconomic, age and race-related inconsistencies in the use of breast reconstruction after mastectomy.

Tags: BreastCancer, Disparities

  • Wendy Y. Chen, MD, MPH, a breast cancer expert at Dana-Farber, has conducted research that shows that food-based soy is safe to eat for breast cancer patients and survivors.

Tags: BreastCancer, Nutrition

  • A gene whose existence was detected only a couple of years ago may increase women's risk of breast cancer when inherited in a mutated form, and may contribute to prostate cancer as well, researchers at Dana-Farber and colleagues in Finland report in a new study.

Tags: BreastCancer, Genomics, Genetics

Showing 11-20 of 55 items